These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

381 related articles for article (PubMed ID: 36987181)

  • 41. Polymeric capsules and micelles as promising carriers of anticancer drugs.
    Kubiak T
    Polim Med; 2022; 52(1):37-50. PubMed ID: 35196423
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cyclodextrin-Based Polymeric Materials Bound to Corona Protein for Theranostic Applications.
    Esmaeilpour D; Broscheit JA; Shityakov S
    Int J Mol Sci; 2022 Nov; 23(21):. PubMed ID: 36362293
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Stimulus-Responsive Degradable Polylactide-Based Block Copolymer Nanoassemblies for Controlled/Enhanced Drug Delivery.
    Bawa KK; Oh JK
    Mol Pharm; 2017 Aug; 14(8):2460-2474. PubMed ID: 28493712
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Preparation and application of cyclodextrin immobilized polysaccharides.
    Yang JS; Yang L
    J Mater Chem B; 2013 Feb; 1(7):909-918. PubMed ID: 32262353
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Recent Development of Copolymeric Delivery System for Anticancer Agents Based on Cyclodextrin Derivatives.
    Feng R; Deng P; Teng F; Song Z
    Anticancer Agents Med Chem; 2016; 16(3):299-308. PubMed ID: 26349814
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Dually acid- and GSH-triggered bis(β-cyclodextrin) as drugs delivery nanoplatform for effective anticancer monotherapy.
    Chen J; Liu H; Li X; Li J; Tang R; Deng Z; Yang Y; Zhong S
    Nanotechnology; 2021 Apr; 32(14):145714. PubMed ID: 33383572
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Advantages of the combined use of cyclodextrins and nanocarriers in drug delivery: A review.
    Mura P
    Int J Pharm; 2020 Apr; 579():119181. PubMed ID: 32112928
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Classification of stimuli-responsive polymers as anticancer drug delivery systems.
    Taghizadeh B; Taranejoo S; Monemian SA; Salehi Moghaddam Z; Daliri K; Derakhshankhah H; Derakhshani Z
    Drug Deliv; 2015 Feb; 22(2):145-55. PubMed ID: 24547737
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Facile modification of nanodiamonds with hyperbranched polymers based on supramolecular chemistry and their potential for drug delivery.
    Huang H; Liu M; Jiang R; Chen J; Mao L; Wen Y; Tian J; Zhou N; Zhang X; Wei Y
    J Colloid Interface Sci; 2018 Mar; 513():198-204. PubMed ID: 29153713
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Research Progress on Synthesis and Application of Cyclodextrin Polymers.
    Liu Y; Lin T; Cheng C; Wang Q; Lin S; Liu C; Han X
    Molecules; 2021 Feb; 26(4):. PubMed ID: 33669556
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Progress in developing amphiphilic cyclodextrin-based nanodevices for drug delivery.
    Yaméogo JB; Géze A; Choisnard L; Putaux JL; Semdé R; Wouessidjewe D
    Curr Top Med Chem; 2014; 14(4):526-41. PubMed ID: 24354667
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Delivery of pharmaceuticals and other active ingredients with their crystalline cyclodextrin inclusion compounds.
    Tonelli AE; Shen J
    Int J Pharm; 2020 Nov; 589():119856. PubMed ID: 32898635
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Drug-Encapsulated Cyclodextrin Nanosponges.
    Tannous M; Caldera F; Hoti G; Dianzani U; Cavalli R; Trotta F
    Methods Mol Biol; 2021; 2207():247-283. PubMed ID: 33113141
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Host-guest interaction and structural ordering in polymeric nanoassemblies: Influence of molecular design.
    Antoniuk I; Plazzotta B; Wintgens V; Volet G; Nielsen TT; Pedersen JS; Amiel C
    Int J Pharm; 2017 Oct; 531(2):433-443. PubMed ID: 28242378
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Construction of β-cyclodextrin-based supramolecular hyperbranched polymers self-assemblies using AB
    Bai Y; Liu CP; Xie FY; Ma R; Zhuo LH; Li N; Tian W
    Carbohydr Polym; 2019 Jun; 213():411-418. PubMed ID: 30879686
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cyclodextrin complexes for treatment improvement in infectious diseases.
    Imperiale JC; Sosnik AD
    Nanomedicine (Lond); 2015 May; 10(10):1621-41. PubMed ID: 26008196
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cyclodextrin-based gene delivery systems.
    Ortiz Mellet C; García Fernández JM; Benito JM
    Chem Soc Rev; 2011 Mar; 40(3):1586-608. PubMed ID: 21042619
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Unimolecular Micelles of Amphiphilic Cyclodextrin-Core Star-Like Copolymers with Covalent pH-Responsive Linkage of Anticancer Prodrugs.
    Jia T; Huang S; Yang C; Wang M
    Mol Pharm; 2017 Aug; 14(8):2529-2537. PubMed ID: 27684093
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Novel pH-Triggered Doxorubicin-Releasing Nanoparticles Self-Assembled by Functionalized β-Cyclodextrin and Amphiphilic Phthalocyanine for Anticancer Therapy.
    Zheng K; Liu X; Liu H; Dong D; Li L; Jiang L; Huang M; Ding C
    ACS Appl Mater Interfaces; 2021 Mar; 13(9):10674-10688. PubMed ID: 33621058
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Electrospinning of nanofibers from non-polymeric systems: polymer-free nanofibers from cyclodextrin derivatives.
    Celebioglu A; Uyar T
    Nanoscale; 2012 Jan; 4(2):621-31. PubMed ID: 22159162
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.